10.4% growth in sales the first nine months of 2008
Berlin (euro adhoc) -
2008 earnings goal confirmed/
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
balance/9-Month Report 2008
Sales of medical device manufacturer WORLD OF MEDICINE grew in the first nine months of 2008 by 10.4% to TEUR27,769. Pre-tax sales yield equaled last year's figure of 15.6%. "The Company is positioned within the corridor that will enable us to achieve the earnings goal for 2008: A pre-tax sales yield of 11%," says Peter P. Wiest, CEO. "However, we are seeing signs of a further slowdown, particularly in the US market, due to the current financial crisis. In view of the consequent risks to projected growth and to our business, we currently anticipate that the Group will fall slightly short of the 2008 sales target - an increase equal to 7%." For the medium term, WORLD OF MEDICINE has firmly secured its position as the global market leader in a significant area of Minimally Invasive Surgery through strategically important projects and a global agreement with a US-based major customer.
Earnings per share in the first nine months of 2008 equaled EUR 0.34. Last year,one-time proceeds from the sale of the former subsidiary, IB Laser, were reported.
| |9M/2008 |9M/2007 |Change
||Sales |TEUR27,769 |TEUR25,142 |+ 10.4% |
|EBT |TEUR4,323 |TEUR3,927 |+ 10.1% |
|Pre-tax sales yield|15.6% |15.6% |+/- 0 % |
|Earnings per share |EUR 0.34 |EUR 0.54 |- 37.0%
(adjusted for |
| | |one-time effect
on income: EUR 0.43) |
|The entire Quarterly Financial Report for the first 9 months of 2008 is available at:
www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2008_wom.pdf
WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS for short. This approach includes safe and gentle surgical procedures conducted through keyhole or puncture incisions, in place of major incisions. The Company is the global market leader in a niche of this future market.
end of announcement euro adhoc
Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com
Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade